Validated xenograft

Tuesday, 21 June 2011 07:50 frontend

Crown Bioscience has established multiple in vivo assay systems to evaluate novel anti-cancer compounds. Each assay is designed to understand specific aspects of each drug property and its mechanism of action. By using our comprehensive capability, our customers can advance development programs in a timely and cost-effective manner. Our highly experienced preclinical team is focused solely on oncology. Our team works with you to choose the most appropriate study design and screening method for an investigational agent.

Oncology Experts

ValidatedXeno^TM

• Subcutaneous Tumor Xenografts View images 1
• Orthotopic Tumor models View images 1, 2, 3, 4
• Syngeneic Tumor models

Premium Efficacy Models

• Metastatic Tumor Models View images 1, 2, 3
• Angiogenesis Models View images 1, 2, 3
• Combination Chemotherapeutic Models View image

AdvantageServices^TM

• Maximum Tolerated Dose Determinations
• In Vitro IC50 Determination
• Biomarker Services

HuPrime Tumorgraft – Genome-defined human primary tumor models